跳到正文
原文
Regulatory Affairs Professionals Society· @RAPSorg · X·· 29 天前精选AI 评分40
AI 导读

RAPS援引一项研究称,2013至2022年间FDA药物评价与研究中心(CDER)的药物咨询委员会会议中,超过三分之一有来自接受行业资助的倡导组织的患者或消费者代表参与。

推荐理由

这条研究结论提示FDA咨询委员会患者代表与行业资助 advocacy 组织存在关联,可供关注审评独立性的读者参考。

正文

More than a third of FDA Center for Drug Evaluation and Research drug advisory committee meetings held between 2013 and 2022 included a patient or consumer representative belonging to an advocacy organization that received industry funding.

https://hubs.la/Q04BxBRG0

来源:Regulatory Affairs Professionals Society · x.com